Illumina is the world leader in gene sequencing technology – the ability to read and record DNA. Now, the billion-dollar company is buying SomaLogic to focus on protein.

A free two-day event in Cambridge will unite experts to discuss translational advances in cell and gene therapy, spanning rare diseases, cancer immunotherapy, and genome editing.

Seamless Therapeutics inks research collaboration with Lilly to develop programmable recombinase-based therapeutics for hearing loss: Dresden, Germany Friday, January 30, 2026, 15 ...

Longevity enthusiasts tell stories of extreme biohacking, post-cryopreservation polyamory and penis injections. Are they onto something?

Sidewinder achieves highly accurate assembly of long DNA sequences from scratch, offering a new leap forward for programmable biology ...

Epigenomics is at the forefront of biomedical innovation, offering unprecedented insights into the mechanisms that regulate ...

A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.

From Google DeepMind’s AlphaGenome decoding DNA to India’s push for sovereign AI infrastructure, this week saw AI stretch ...

It took a quarter century of dead ends and strange leads before DNA evidence led a family to the real killer of Herman Wilder of Dahlonega.

While artificial intelligence (AI) technology sweeps across the globe, reshaping industries from finance to ...

London/Hyderabad: Dr Sirisha Senthil from Hyderabad, head of the VST Centre for Glaucoma Care at LV Prasad Eye Institute (LVPEI), is the third Indian to deliver the Noel Rice Lecture 2026 in London.

Columnist Michael Le Page delves into a catalogue of hundreds of potentially beneficial gene mutations and variants that is ...